Life-course approach to cognitive ageing;Approche « vie entière » dans l'étude du vieillissement cognitif

Medecine/Sciences

Volumn 26, Issue 3, 2010, Pages 319-324

  Sabia, Séverine ^a   Ankri, Joël ^b,c   Singh Manoux, Archana ^a,b,d  

^a HÔPITAL PAUL BROUSSE   (France)

^b Versailles Saint Quentin en Yvelines University   (France)

^c Île de France Ouest University Paris   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; HUMAN; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; COHORT STUDIES; HUMANS; MIDDLE AGED; QUESTIONNAIRES;

EID: 77953116480     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2010263319     Document Type: Review

References (61)

1. Ritchie K, Lovestone S. The dementias. Lancet 2002; 360: 1759-66.
2. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-7.
3. Brayne C. The elephant in the room - healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 2007; 8: 233-9.
4. Helmer C, Pasquier F, Dartigues JF. Epidemiology of Alzheimer disease and related disorders. Med Sci (Paris) 2006; 22: 288-96.
5. Hachinski V. Shifts in thinking about dementia. JAMA 2008; 300: 2172-3.
6. Holland CA, Rabbitt PMA. The course and causes of cognitive change with advancing age. Rev Clin Gerontol 1991; 1: 81-96.
7. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms. Ann Neurol 2008; 64: 492-8.
8. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997; 9: 65-9.
9. Chertkow H. Mild cognitive impairment. Curr Opin Neurol 2002; 15: 401-7.
10. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006; 367: 1262-70.
11. Ska B, Joanette Y. Normal aging and cognition. Med Sci (Paris) 2006; 22: 284-7.
12. Whalley LJ, Dick FD, McNeill G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 2006; 5: 87-96.
13. Kivipelto M, Ngandu T, Laatikainen T, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006; 5: 735-41.
14. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62: 1556-60.
15. Anttila T, Helkala EL, Viitanen M, et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ 2004; 329: 539.
16. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001; 322: 1447-51.
17. Rovio S, Kareholt I, Helkala EL, et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005; 4: 705-11.
18. Launer LJ. The epidemiologic study of dementia: a life-long quest? Neurobiol Aging 2005; 26: 335-40.
19. Kuh D, Ben-Shlomo Y. Introduction: A lifecourse approach to the aetiology of chronic diseases. In: Kuh D, Ben-Shlomo Y, Eds. A lifecourse approach to chronic disease epidemiology. Oxford: Oxford University Press, 1997: 3-14.
20. Gustafson D. Adiposity indices and dementia. Lancet Neurol 2006; 5: 713-20.
21. Elias MF, Sullivan LM, D'Agostino RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004; 35: 404-9.
22. Richards M, Jarvis MJ, Thompson N, Wadsworth ME. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health 2003; 93: 994-8.
23. Cournot M, Marquie JC, Ansiau D, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006; 67: 1208-14.
24. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274: 1846-51.
25. Richards M, Hardy R, Wadsworth ME. Alcohol consumption and midlife cognitive change in the British 1946 birth cohort study. Alcohol Alcohol 2005; 40: 112-7.
26. Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol 2005; 58: 1308-15.
27. Singh-Manoux A, Sabia S, Lajnef M, et al. History of coronary heart disease and cognitive deficit in midlife: the Whitehall II study. Eur Heart J 2008; 29: 2100-7.
28. Wolf PA, Beiser A, Elias MF, et al. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res 2007; 4: 111-6.
29. Anstey KJ, von SC, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166: 367-78.
30. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetessystematic overview of prospective observational studies. Diabetologia 2005; 48: 2460-9.
31. Espeland MA, Gu L, Masaki KH, et al. Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Am J Epidemiol 2005; 161: 228-38.
32. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27: 2230-5.
33. Kang JH, Ascherio A, Grodstein F. Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol 2005; 57: 713-20.
34. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 2008; 37: 505-12.
35. Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol 2005; 34: 251-6.
36. Heim AW. AH 4 group test of general Intelligence. Windsor, UK: NFER-Nelson Publishing Company Ltd., 1970.
37. Raven JC. Guide to using the Mill Hill vocabulary test with progressive matrices. London, UK: HK Lewis, 1965.
38. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologica 1967; 5: 135-40.
39. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
40. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002; 8: 448-60.
41. Stern Y. The concept of cognitive reserve: a catalyst for research. J Clin Exp Neuropsychol 2003; 25: 589-93.
42. Singh-Manoux A, Richards M, Marmot M. Socioeconomic position across the lifecourse: how does it relate to cognitive function in mid-life? Ann Epidemiol 2005; 15: 572-8.
43. Akbaraly TN, Singh-Manoux A, Marmot MG, Brunner EJ. Education attenuates the association between dietary patterns and cognition. Dement Geriatr Cogn Disord 2009; 27: 147-54.
44. Singh-Manoux A, Britton A, Kivimaki M, et al. Socioeconomic status moderates the association between carotid intima-media thickness and cognition in midlife: evidence from the Whitehall II study. Atherosclerosis 2008; 197: 541-8.
45. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006; 2: CD004034.
46. Stewart R, White LR, Xue QL, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2007; 64: 103-7.
47. Brayne C. Smoking and the brain. BMJ 2000; 320: 1087-8.
48. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a metaanalysis. Arch Phys Med Rehabil 2004; 85: 1694-704.
49. Singh-Manoux A, Britton AR, Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II Study. J Am Geriatr Soc 2003; 51: 1445-50.
50. Kumari M, Marmot M. Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology 2005; 65: 1597-603.
51. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II Study. Arterioscler Thromb Vasc Biol 2008; 28: 1556-62.
52. WHO. Cardiovascular diseases. http://www who int/mediacentre/ factsheets/fs317/en/print html 2007Available from: URL: http://www. who.int/mediacentre/factsheets/fs317/en/print.html
53. Britton A, Singh-Manoux A, Marmot M. Alcohol consumption and cognitive function in the Whitehall II Study. Am J Epidemiol 2004; 160: 240-7.
54. Singh-Manoux A, Hillsdon M, Brunner E, Marmot M. Effects of physical activity on cognitive functioning in middle age: evidence from the Whitehall II prospective cohort study. Am J Public Health 2005; 95: 2252-8.
55. Sabia S, Dufouil C, Marmot MG, Singh-Manoux A. Smoking history and cognitive function in middle-age in Whitehall II study. Arch Intern Med 2008; 168: 1165-73.
56. Sabia S, Kivimaki M, Shipley M, Marmot M, Singh-Manoux A. Body mass index over the adult lifecourse and cognition in late midlife: the Whitehall II cohort study. Am J Clin Nutr 2009; 89: 601-7.
57. Singh-Manoux A, Richards M, Marmot M. Leisure activities and cognitive function in middle age: evidence from the Whitehall II study. J Epidemiol Community Health 2003; 57: 907-13.
58. Sabia S, Guéguen A, Marmot MG, et al. Does cognition predict mortality in midlife? Results from the Whitehall II cohort study. Neurobiol Aging 2008; in press.
59. Kuh D, Richards M, Hardy R, Butterworth S, Wadsworth ME. Childhood cognitive ability and deaths up until middle age: a post-war birth cohort study. Int J Epidemiol 2004; 33: 408-13.
60. Elovainio M, Kivimaki M, Ferrie J, et al. Physical and cognitive function in midlife: reciprocal effects? A 5-year follow-up of the Whitehall II study. J Epidemiol Community Health 2009; 63: 468-73.
61. Ferrie JE, Kivimaki M, Singh-Manoux A, et al. Non-response to baseline, non-response to follow-up and mortality in the Whitehall II cohort. Int J Epidemiol 2009; 38: 831-7.